Delivery Order SPE2DB22D3016-SPE2DB25FAJA5
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$50K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,537.14, is for the delivery of M-M-R II vaccine vials. This is a firm fixed-price delivery order contract with a completion date of May 21, 2024. The contract does not have a set-aside designation.
Additionally, Amerisourcebergen Drug Corp holds a larger Indefinite...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,559.44 and an ultimate completion date of December 4, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of M-M-R II vaccine vials. The $7,382.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on October 16, 2024, with a completion date of October 17, 2024. The contract is not designated as a set-aside.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,825.42 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of December 10, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $15,053.96 firm fixed price delivery order contract to provide M-M-R II vaccine vials. This award is part of a larger, single-award indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of M-M-R II vaccine vials. The contract, valued at $54,270.30, is a firm-fixed-price delivery order with a period of performance through June 26, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with a ceiling value of $1,084.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the procurement of M-M-R II vaccine vials. The IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for providing a...
The federal contract award is for the delivery of M-M-R II vaccine vials to the Defense Logistics Agency (DLA), a Defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,837.56 and a completion date of March 20, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,242.77, is for the delivery of M-M-R II vaccine vials, with a completion date of December 3, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The contract is valued at $3,737.16 and has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00...